SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-165187
Filing Date
2013-04-22
Accepted
2013-04-22 17:16:27
Documents
2
Period of Report
2013-06-06
Effectiveness Date
2013-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d523073ddef14a.htm DEF 14A 628628
2 GRAPHIC g523073g08f79.jpg GRAPHIC 16499
  Complete submission text file 0001193125-13-165187.txt   652671
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23155 | Film No.: 13774514
SIC: 2836 Biological Products, (No Diagnostic Substances)